PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24796787 ↗2014Reported benefit

Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney.

RatIschaemia-reperfusionRenalSpontaneously hypertensive rat (SHR)malen = 9 rats in the losartan treated acute renal failure groupIntravenous infusion into the femoral vein10 mg/kg body mass dissolved in 4 mL salineGiven 5 min before ischaemia, during ischaemia and for 175 min after ischaemia

Model: Right nephrectomy with 40 min clamping of the left renal artery followed by 24 h reperfusion, giving ischaemic acute renal failure

Losartan increased creatinine and urea clearance and HDL, reduced plasma lipid peroxidation, increased erythrocyte catalase, reduced cortico-medullary necrosis and tubular dilatation, and downregulated Bax.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.